IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?

LB Pharmaceuticals is on a tear. The IPO stock has more than tripled as investors watch its efforts in neuropsychiatric disorders. The post IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target? appeared first on Investor's Business Daily.